Key facts
- Manuals
- 1
- Languages
- ZH
- Last added
- 2026-11-10
Featured 赫赛莱 manuals

Kadcyla Trastuzumab Emtansine for Injection Package Insert (赫赛莱)
This is the Chinese package insert for Kadcyla (赫赛莱), trastuzumab emtansine for injection, a HER2-targeted antibody-drug conjugate supplied as a white to off-white sterile lyophilized powder for intravenous infusion in 100 mg and 160 mg vials. It states the drug name, active ingredient and excipients, molecular weight, description, indications in early and metastatic HER2-positive breast cancer, and the available strengths.
The document sets out the recommended dose of 3.6 mg/kg every three weeks, the 90-minute first infusion with observation for at least 90 minutes and the possible 30-minute later infusions, treatment duration for early and advanced breast cancer, dose-reduction levels and dose-adjustment tables for liver enzyme, bilirubin, platelet, left ventricular and pulmonary events, dosing in special populations, and instructions for reconstitution, handling and disposal. This manual is written in Chinese.
Covers: Warnings · Drug Name · Ingredients · Description · Indications · Specifications
Latest 赫赛莱 manuals
Kadcyla Trastuzumab Emtansine for Injection Package Insert (赫赛莱)
User Manual 24 pages · 1.6 MB · ZHChinese package insert for Kadcyla (trastuzumab emtansine) 100 mg and 160 mg for injection: indications, dosing, dose adjustment tables and warnings.
Which document do I need?
User Manual
Day-to-day operation, settings and troubleshooting. Start here if the product is already set up.
Questions answered in 赫赛莱 manuals
What is the recommended dose of Kadcyla?
The recommended dose is 3.6 mg/kg given by intravenous infusion once every 3 weeks, with a 21-day cycle.
From: Kadcyla Trastuzumab Emtansine for Injection Package Insert (赫赛莱)
What vial strengths are available?
The product is supplied in 100 mg/vial and 160 mg/vial strengths.
From: Kadcyla Trastuzumab Emtansine for Injection Package Insert (赫赛莱)
